history shows us that a capital raise is always likely if the share price runs high enough, this is with all ASX listed companies and in all industries.
From the company's point of view it's the best way to decrease the amount of dilution you would get from a capital raise- by raising at higher prices = less shares on issues which results in less dilution.
A capital raise will eventually come this year or next if catalysts are met so it's essentially inevitable, this will be due to project funding. They could do majority capital raise with a small debt funding package aswel.
I'm confident that CXO will focus on getting the lithium project fast tracked and I believe it is in the best interest of yahua to help this process potentially by supporting the project financing and updating the offtake agreement to include more Tonnes PA. Capex is very low thanks to the logistics/location of the project, it would makes sense for both parties to come together and build their relationship.
They may aswel give the remaining offtake to them provided they help with project construction and financing, unless Ofcourse it has already been promised to another entity.
- Forums
- ASX - By Stock
- CXO
- Banter and general comments
Banter and general comments, page-77
-
- There are more pages in this discussion • 38,093 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXO (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $299.1M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 39200 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 68273 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 55200 | 0.145 |
38 | 1652213 | 0.140 |
70 | 3342156 | 0.135 |
73 | 2564616 | 0.130 |
31 | 1067438 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 58273 | 9 |
0.145 | 4326606 | 53 |
0.150 | 2734409 | 65 |
0.155 | 2662530 | 51 |
0.160 | 2954345 | 43 |
Last trade - 09.48am 07/05/2024 (20 minute delay) ? |
|
|||||
Last
14.3¢ |
  |
Change
0.000 ( 1.14 %) |
|||
Open | High | Low | Volume | ||
14.3¢ | 14.3¢ | 14.3¢ | 3500 | ||
Last updated 10.02am 07/05/2024 ? |
Featured News
CXO (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online